Therapeutic potential of peptide motifs--part II.
Hervé
Jean-Claude
JC
D020816:Amino Acid Motifs; D000818:Animals; D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use; D023181:Antimicrobial Cationic Peptides / Q000502:physiology / Q000627:therapeutic use; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors / Q000502:physiology; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000502:physiology / Q000627:therapeutic use; D018733:Nicotinic Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D010455:Peptides / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use; D017510:Protein Folding / Q000187:drug effects; D047428:Protein Kinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D020741:rho GTP-Binding Proteins / Q000502:physiology
D019380:Anti-HIV Agents; D023181:Antimicrobial Cationic Peptides; D036341:Intercellular Signaling Peptides and Proteins; D018733:Nicotinic Antagonists; D010455:Peptides; D047428:Protein Kinase Inhibitors; D018844:Cyclin-Dependent Kinases; D020741:rho GTP-Binding Proteins